BioCentury
ARTICLE | Company News

Arbor Pharmaceuticals deal

April 26, 2010 7:00 AM UTC

An investment group led by Jason Wild of JW Asset Management LLC and Edward Schutter acquired Arbor for an undisclosed sum. Wild was named chairman, and Schutter was named CEO and a director of the company. Schutter was president and COO of Sciele Pharma Inc. prior to its acquisition by Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507, Osaka, Japan). Allen Chao, former founder and CEO of Watson Pharmaceuticals Inc. (NYSE:WPI, Corona, Calif.) and a member of the investment group, was also appointed a director. Jarret Disbrow, Arbor's founder and CEO prior to the acquisition, will transition to VP of commercial development. ...